fundc1 Antibody

What is FUNDC1 and what structural characteristics define this protein?

FUNDC1 is an integral mitochondrial outer-membrane protein with a calculated molecular weight of approximately 17 kDa (155 amino acids). It contains the conserved FUN14 domain and functions primarily at mitochondria-associated endoplasmic reticulum membranes (MAMs) . The protein's structure includes critical regions that facilitate protein-protein interactions, particularly the cytosolic domain (amino acids 96-138) which is essential for interaction with calnexin, with the minimal interaction region narrowed to amino acids 129-138 . Additionally, the first transmembrane domain (amino acids 50-68) has been identified as critical for FUNDC1's interaction with calnexin . These structural elements are important considerations when selecting antibodies targeting specific epitopes.

What applications are FUNDC1 antibodies validated for?

FUNDC1 antibodies have been validated for multiple research applications, with Western blot (WB) being the most commonly reported. Based on published literature and commercial validation data:

It's important to note that optimal dilutions may be sample-dependent and should be determined empirically for each experimental system to obtain optimal results .

What species reactivity is observed with FUNDC1 antibodies?

FUNDC1 antibodies show cross-reactivity with multiple species, making them versatile tools for comparative studies:

When studying FUNDC1 in species not listed as validated, preliminary tests should be conducted to confirm reactivity before proceeding with full experiments.

How can researchers effectively study FUNDC1's role in mitochondrial dynamics and mitophagy?

FUNDC1 plays a crucial role in mitochondrial fission and mitophagy, particularly under hypoxic conditions. To study these processes:

• Hypoxia-induced mitophagy: FUNDC1 acts as an activator of hypoxia-induced mitophagy by interacting with and recruiting LC3 protein family to mitochondria . Experimental approaches should include:

  • Co-immunoprecipitation assays to detect FUNDC1-LC3 interactions

  • Immunofluorescence microscopy to visualize co-localization

  • Live-cell imaging with fluorescently tagged proteins to track mitophagy progression

• Mitochondrial fission: FUNDC1 recruits DRP1 at ER-mitochondria contact sites, leading to DRP1 oligomerization and GTPase activity that facilitates mitochondrial fission during hypoxia . Researchers should consider:

  • Transfection of FLAG-DRP1 and FUNDC1-MYC followed by co-immunoprecipitation to study their interaction

  • Immunofluorescence to detect colocalization of FUNDC1-MYC and endogenous DRP1

  • Knockdown studies (FUNDC1 KD) to observe effects on DRP1 translocation to mitochondria under hypoxic conditions

• Methodological considerations: When studying FUNDC1's role in these processes, hypoxic conditions should be carefully controlled and validated. Effects of FUNDC1 manipulation should be compared with knockdown of other mitochondrial dynamics proteins such as FIS1, MID49/51, or MFF to distinguish FUNDC1-specific effects .

What approaches should be used to investigate FUNDC1's interactions with ER proteins and its role at MAMs?

FUNDC1 is enriched at mitochondria-associated ER membranes (MAMs) by interacting with the ER resident protein calnexin (CANX) under hypoxia . To study these interactions:

• Domain-specific interaction studies: To identify which domains of FUNDC1 are essential for interaction with ER proteins:

  • Generate various mutants of FUNDC1-MYC and transfect into cells

  • Immunoprecipitate with anti-calnexin antibody and analyze interaction

  • Create smaller deletions within critical regions (e.g., AA 96-138) to narrow down key interaction sites

• MAM isolation and analysis:

  • Use subcellular fractionation techniques to isolate MAM fractions

  • Compare FUNDC1 enrichment in MAMs under normoxic versus hypoxic conditions

  • Analyze the protein composition of MAMs with and without FUNDC1 manipulation

• Dynamic interaction analysis: As mitophagy proceeds, FUNDC1 dissociates from CANX and preferentially recruits DNM1L/DRP1 . This dynamic process can be studied using:

  • Time-course experiments following hypoxia induction

  • Proximity labeling techniques like BioID or APEX to identify temporal changes in FUNDC1 interactome

  • FRET or BRET approaches to monitor protein-protein interactions in real-time

What experimental strategies can reveal FUNDC1's role in cardiac function and lipotoxicity?

FUNDC1 plays an essential role in preserving mitochondrial Ca²⁺ homeostasis and cardiac function in obese hearts through interaction with FBXL2 . Research approaches should include:

• FUNDC1-FBXL2 interaction studies:

  • Flag-tagged FUNDC1 overexpression followed by immunoprecipitation and mass spectrometry identified FBXL2 as an interacting partner

  • Co-immunoprecipitation in cardiac cells (e.g., H9c2) confirms this interaction

  • Liquid chromatography-mass spectrometry (LC-MS) analysis can identify additional proteins recovered in the immunoprecipitate

• Mitochondrial calcium regulation:

  • Monitor high-fat diet-induced changes in ER proteins and FBXL2 in wild-type versus FUNDC1-ablated models

  • Examine IP3R3 levels, which are regulated by FBXL2-mediated degradation

  • FUNDC1 ablation accentuates high-fat diet-induced up-regulation of IP3R3

• Lipotoxicity models:

  • Challenge cardiomyocytes with palmitic acid to induce lipotoxicity

  • Assess cytochrome C release from mitochondria to cytosol along with nuclear cytochrome C buildup

  • FUNDC1 transfection, FBXL2 activator BC-1258, or the IP3R3 inhibitor 2-APB can reverse these adverse effects

  • Disruption of FBXL2 localization with GGTi-2418 negates FUNDC1-mediated benefits

• Protein stability assessment:

  • Pulse-chase analysis to examine time-dependent changes in FBXL2 and IP3R3 levels upon palmitic acid challenge

  • Assess how FUNDC1 ablation or overexpression affects these patterns

  • Protease inhibitors like MG132 can be used to assess the role of proteasomal degradation

What are the optimal storage and handling conditions for FUNDC1 antibodies?

Proper storage and handling of FUNDC1 antibodies are critical for maintaining their functionality and specificity:

When working with FUNDC1 antibodies, avoid repeated freeze-thaw cycles to preserve antibody integrity. For long-term experiments, consider dividing the antibody into working aliquots despite the manufacturer's note about aliquoting being unnecessary.

What controls should be included in FUNDC1 antibody-based experiments?

Proper experimental controls are essential for generating reliable data with FUNDC1 antibodies:

• Positive controls: Include samples known to express FUNDC1:

  • For Western blot: RAW 264.7 cells, mouse/rat brain tissue, mouse/rat liver tissue, and C6 cells have been validated

  • For other applications: Use cell lines with confirmed FUNDC1 expression

• Negative controls:

  • FUNDC1 knockout or knockdown samples should be used to confirm antibody specificity

  • Isotype control antibodies (Rabbit IgG for polyclonal antibodies ) help identify non-specific binding

• Loading controls:

  • For mitochondrial proteins: VDAC, TOM20, or cytochrome c oxidase

  • For whole cell lysates: β-actin, GAPDH, or tubulin

• Subcellular fractionation verification:

  • When studying FUNDC1 at MAMs, include markers for mitochondria (e.g., TOM20), ER (e.g., calnexin), and MAMs to verify fraction purity

How can researchers troubleshoot common issues with FUNDC1 detection in Western blots?

Western blotting is the most validated application for FUNDC1 antibodies. When troubleshooting detection issues:

• No signal or weak signal:

  • Check protein loading amounts (FUNDC1 is expressed at moderate levels)

  • Adjust antibody dilution (recommended range 1:5000-1:20000 )

  • Extend primary antibody incubation time or temperature

  • Ensure transfer efficiency for the 17 kDa protein (observed molecular weight )

  • Consider using enhanced chemiluminescence detection systems

• Multiple bands:

  • Verify sample preparation (complete denaturation, fresh samples)

  • Increase blocking stringency (5% BSA or milk, longer blocking time)

  • Adjust washing conditions (increase wash duration/frequency)

  • Compare with knockout/knockdown samples to identify specific bands

  • Note that post-translational modifications or alternative splicing may result in additional specific bands

• Inconsistent results:

  • Standardize lysate preparation (consistent lysis buffers, protease inhibitors)

  • Control for hypoxic conditions, which affect FUNDC1 localization and interactions

  • Consider the effects of cellular stress on FUNDC1 expression and modification

What are the key considerations when studying FUNDC1's role in ferroptosis?

FUNDC1 plays a role in hepatic ferroptosis by interacting directly with glutathione peroxidase (GPX4) and facilitating its recruitment into mitochondria through the TOM/TIM complex where it is degraded by mitophagy . When studying this process:

• Experimental approaches:

  • Co-immunoprecipitation assays to detect FUNDC1-GPX4 interaction

  • Subcellular fractionation to track GPX4 translocation to mitochondria

  • Mitophagy assays to monitor GPX4 degradation

• Methodological considerations:

  • Induce ferroptosis using established inducers (e.g., erastin, RSL3)

  • Monitor mitochondrial lipid peroxidation as a marker of ferroptosis

  • Include inhibitors of ferroptosis (ferrostatin-1) and mitophagy to distinguish between pathways

  • Measure GPX4 activity in addition to protein levels to assess functional effects

• Validation strategies:

  • Compare FUNDC1 knockout/knockdown with GPX4 manipulation

  • Use mitochondria-targeted antioxidants to differentiate between mitochondrial and cytosolic oxidative stress

  • Analyze the temporal relationship between FUNDC1-GPX4 interaction and onset of ferroptotic cell death

How can FUNDC1 antibodies be used in multiplexed imaging applications?

For researchers investigating FUNDC1's dynamic interactions with multiple partners at specialized subcellular locations, multiplexed imaging approaches are valuable:

• Multi-color immunofluorescence:

  • Combine FUNDC1 antibodies with markers for mitochondria, ER, autophagosomes, and interaction partners

  • Use spectrally distinct fluorophores and careful antibody selection to avoid cross-reactivity

  • Super-resolution microscopy techniques (STED, STORM, PALM) can provide nanoscale resolution of FUNDC1 localization at contact sites

• Proximity ligation assays (PLA):

  • Detect in situ FUNDC1 interactions with calnexin, DRP1, LC3, FBXL2, or GPX4

  • Quantify interaction events in different cellular compartments or under various conditions

  • Combine with time-lapse imaging to track dynamic changes in protein interactions

• Live-cell imaging considerations:

  • When using antibody-based detection methods, cell permeabilization is required, limiting live-cell applications

  • Consider complementary approaches with fluorescently tagged proteins for real-time studies

  • Photoswitchable or photoactivatable tags can help track FUNDC1 dynamics at specific subcellular locations

What strategies can address data inconsistencies in FUNDC1 research?

Researchers may encounter seemingly contradictory results when studying FUNDC1 function across different experimental systems. To reconcile such inconsistencies:

• Cell type and tissue specificity:

  • FUNDC1 functions may vary between cell types (e.g., cardiomyocytes vs. hepatocytes)

  • Compare FUNDC1 expression levels and interacting partners across different cell types

  • Consider using tissue-specific conditional knockout models rather than global knockouts

• Acute vs. chronic manipulations:

  • Distinguish between acute (siRNA) and chronic (stable knockout) FUNDC1 depletion

  • Compensatory mechanisms may mask phenotypes in chronic models

  • Use inducible systems (e.g., Tet-On/Off) to control the timing of FUNDC1 manipulation

• Stress conditions:

  • FUNDC1 functions prominently under specific stresses (hypoxia, lipotoxicity)

  • Standardize stress induction protocols and carefully report parameters

  • Consider the duration and severity of stress when comparing results across studies

• Experimental validation approaches:

  • Validate key findings using multiple complementary techniques

  • When comparing with published literature, consider differences in antibody clones, epitopes, and validation methods

  • Rescue experiments (re-expressing FUNDC1 in knockout backgrounds) provide strong evidence for specificity

What resources are available for researchers studying FUNDC1?

Researchers interested in studying FUNDC1 can access various resources:

• Antibody validation data:

  • Commercial antibody providers offer validation data including Western blot images, application-specific protocols, and recommended dilutions

  • Published literature citing specific antibody catalog numbers provides real-world validation

• Experimental protocols:

  • Specific protocols for FUNDC1 antibody applications are available from manufacturers

  • Published methods sections in FUNDC1 research papers provide detailed protocols for specialized applications

• Model systems:

  • Cell lines with validated FUNDC1 expression include RAW 264.7, C6, HeLa, and H9c2

  • Tissues with confirmed expression include brain and liver from mouse and rat

• Genetic tools:

  • FUNDC1 knockout models have been described in literature for studying cardiac function

  • Expression constructs for wild-type and mutant FUNDC1 enable structure-function studies